Parthian Medical Services Limited 15998692 false 2024-10-04 2025-10-31 2025-10-31 The principal activity of the company is that of providing Acute and General Medical services to BUPA Cromwell Hospital in London and medicolegal expert opinions in Acute and General Medicine to TMLEP Ltd Digita Accounts Production Advanced 6.30.9574.0 true 15998692 2024-10-04 2025-10-31 15998692 2025-10-31 15998692 bus:OrdinaryShareClass1 bus:OtherShareType 2025-10-31 15998692 core:RetainedEarningsAccumulatedLosses 2025-10-31 15998692 core:CurrentFinancialInstruments 2025-10-31 15998692 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 15998692 core:OfficeEquipment 2025-10-31 15998692 bus:SmallEntities 2024-10-04 2025-10-31 15998692 bus:AuditExemptWithAccountantsReport 2024-10-04 2025-10-31 15998692 bus:FilletedAccounts 2024-10-04 2025-10-31 15998692 bus:SmallCompaniesRegimeForAccounts 2024-10-04 2025-10-31 15998692 bus:RegisteredOffice 2024-10-04 2025-10-31 15998692 bus:Director1 2024-10-04 2025-10-31 15998692 bus:Director2 2024-10-04 2025-10-31 15998692 bus:OrdinaryShareClass1 bus:OtherShareType 2024-10-04 2025-10-31 15998692 bus:PrivateLimitedCompanyLtd 2024-10-04 2025-10-31 15998692 bus:Agent1 2024-10-04 2025-10-31 15998692 core:RetainedEarningsAccumulatedLosses 2024-10-04 2025-10-31 15998692 core:OfficeEquipment 2024-10-04 2025-10-31 15998692 core:PlantMachinery 2024-10-04 2025-10-31 15998692 core:UKTax 2024-10-04 2025-10-31 15998692 countries:UnitedKingdom 2024-10-04 2025-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 15998692

Parthian Medical Services Limited

Annual Report and Unaudited Financial Statements

for the Period from 4 October 2024 to 31 October 2025

 

Parthian Medical Services Limited

Company Information

Directors

Dr Ashkan Sadighi

Mr Mohammad Bagher Sadighi

Registered office

11 Castlegate
Richmond
England
TW9 2HL

Accountants

Mehta & Tengra
Chartered Accountants9 Berners Place
London
W1T 3AD

 

Parthian Medical Services Limited

(Registration number: 15998692)
Balance Sheet as at 31 October 2025

Note

2025
£

Fixed assets

 

Tangible assets

5

1,037

Current assets

 

Debtors

6

7,566

Cash at bank and in hand

 

56,236

 

63,802

Creditors: Amounts falling due within one year

7

(14,906)

Net current assets

 

48,896

Net assets

 

49,933

Capital and reserves

 

Retained earnings

49,933

Shareholders' funds

 

49,933

For the financial period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 July 2026 and signed on its behalf by:
 

.........................................
Dr Ashkan Sadighi
Director

 

Parthian Medical Services Limited

Statement of Changes in Equity for the Period from 4 October 2024 to 31 October 2025

Retained earnings
£

Total
£

Profit for the period

49,933

49,933

At 31 October 2025

49,933

49,933

 

Parthian Medical Services Limited

Notes to the Unaudited Financial Statements for the Period from 4 October 2024 to 31 October 2025

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
11 Castlegate
Richmond
TW9 2HL
England

These financial statements were authorised for issue by the Board on 30 July 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

1/3 of cost

 

Parthian Medical Services Limited

Notes to the Unaudited Financial Statements for the Period from 4 October 2024 to 31 October 2025

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

4

Taxation

Tax charged/(credited) in the profit and loss account

2025
£

Current taxation

UK corporation tax

13,106

 

Parthian Medical Services Limited

Notes to the Unaudited Financial Statements for the Period from 4 October 2024 to 31 October 2025

5

Tangible assets

Office equipment
£

Total
£

Cost or valuation

Additions

1,556

1,556

At 31 October 2025

1,556

1,556

Depreciation

Charge for the period

519

519

At 31 October 2025

519

519

Carrying amount

At 31 October 2025

1,037

1,037

6

Debtors

Current

2025
£

Directors' loan account

7,566

 

7,566

7

Creditors

Creditors: amounts falling due within one year

2025
£

Due within one year

Corporation tax

13,106

Accruals and deferred income

1,800

14,906

8

Share capital

Allotted, called up and fully paid shares

2025

No.

£

Ordinary shares of £1 each

100

100